Connecticut Cannabis Sales
Feb, 2026
Overview
Connecticut’s cannabis market has established itself as a steady, mid-sized player, with total sales reaching $22.2 million in February 2026. Over the past year, the market has shown resilience, posting a slight year-over-year sales increase of 0.2% despite some volatility in monthly growth rates. While the market has experienced both positive and negative swings month-to-month, the overall trend points to a stable consumer base and a maturing retail environment.
Pricing in Connecticut remains notably higher than most other states, with an average item price of $28.19 in February 2026. This premium pricing reflects both the state’s regulatory environment and limited competition compared to larger, more established markets. Despite these higher prices, Connecticut has seen a 26.9% year-over-year increase in units sold, indicating growing consumer demand and increased accessibility.
Feb, 2026
Sales
Year Over Year
Growth
Market Comparison
Connecticut’s market is smaller than major cannabis states but stands out for its high average item price and strong unit growth. Here’s how CT compares to select states in February 2026:
Connecticut Weed Prices
| State | Total Sales ($M) | Avg. Item Price ($) | YoY Sales Growth | YoY Unit Growth |
|---|---|---|---|---|
| California | 286.9 | 18.44 | -6.4% | -2.6% |
| Michigan | 206.2 | 8.88 | -14.8% | -7.6% |
| New York | 163.5 | 31.29 | 54.8% | 75.2% |
| Massachusetts | 120.0 | 17.69 | -2.3% | 0.2% |
| Illinois | 113.3 | 28.47 | -10.2% | -6.4% |
| Connecticut | 22.2 | 28.19 | 0.2% | 26.9% |
| New Jersey | 83.9 | 31.27 | -2.3% | 6.5% |
Category Performance
While Flower and Vapor Pens dominate sales in most markets, Connecticut’s Pre-Roll category is experiencing a unique growth trajectory. Pre-Rolls posted $3.27 million in sales in February 2026, with a 23.9% year-over-year growth in sales and an impressive 109.6% increase in units sold. This surge is driven by falling prices (down to $14.18 per item) and a shift toward more affordable, accessible products.
Within Pre-Rolls, the Hybrid - Single Strain segment leads, with $1.95 million in sales and a 164.7% year-over-year increase in units sold. The Connoisseur/Infused and Indica - Single Strain segments are also showing strong growth, reflecting consumer interest in both premium and value options.
| Brand Name | Total Sales ($M) | Units Sold | Avg. Price ($) |
|---|---|---|---|
| CTPharma | 0.46 | 17,583 | 26.10 |
| Theraplant | 0.38 | 15,499 | 24.49 |
| Grassroots | 0.28 | 17,438 | 16.23 |
| Springtime | 0.24 | 29,822 | 8.11 |
| Comffy | 0.23 | 15,177 | 15.14 |
| Awssom | 0.23 | 29,385 | 7.77 |
| AGL / Advanced Grow Labs | 0.23 | 17,382 | 12.97 |
| Curaleaf | 0.21 | 14,270 | 14.58 |




